VBCG
GH icon

Valley Brook Capital Group’s Guardant Health GH Stock Holding History

Valley Brook Capital Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$15K – 224
2021
Q1 		$15K Hold
100
– – 0.01% 330
2020
Q4 		$12K Buy
+100
New +$11.5K 0.01% 318

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Valley Brook Capital Group's GH Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Guardant Health (GH) in Q2 2021, closing a stake of 100 shares — an estimated $15K sold.

Valley Brook Capital Group first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $15K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 100 Guardant Health shares in Q2 2021, an estimated $15K.
  • Valley Brook Capital Group first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Guardant Health position peaked at $15K in Q1 2021.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.